Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients
Clinical and Translational Oncology, 07/18/2012
Jeremic B et al. – This study reconfirmed low acute and late high–grade toxicity in stage III non–small cell lung cancer (NSCLC) treated with concurrent radiation therapy (RT) with or without concurrent chemotherapy (CHT) and identified factors influencing it.
